YÜCEL, O. K. 2023. The First 100-day Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients: Melphalan 200 mg/m² versus 140 mg/m² Conditioning Regimen. Turkish Journal of Clinics and Laboratory , vol.14, no.3 , 608-615.

YÜCEL, O. K., (2023). The First 100-day Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients: Melphalan 200 mg/m² versus 140 mg/m² Conditioning Regimen. Turkish Journal of Clinics and Laboratory , vol.14, no.3, 608-615.

YÜCEL, ORHAN. "The First 100-day Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients: Melphalan 200 mg/m² versus 140 mg/m² Conditioning Regimen," Turkish Journal of Clinics and Laboratory , vol.14, no.3, 608-615, 2023

YÜCEL, ORHAN K. . "The First 100-day Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients: Melphalan 200 mg/m² versus 140 mg/m² Conditioning Regimen." Turkish Journal of Clinics and Laboratory , vol.14, no.3, pp.608-615, 2023

YÜCEL, O. K. (2023) . "The First 100-day Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients: Melphalan 200 mg/m² versus 140 mg/m² Conditioning Regimen." Turkish Journal of Clinics and Laboratory , vol.14, no.3, pp.608-615.

@article{article, author={ORHAN KEMAL YÜCEL}, title={The First 100-day Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients: Melphalan 200 mg/m² versus 140 mg/m² Conditioning Regimen}, journal={Turkish Journal of Clinics and Laboratory}, year=2023, pages={608-615} }